Column Group LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001833486 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 15, 2025

Total Value: $65.72M (100.0% shares, 0.0% debt)

Holdings (5)

ORIC ORIC Pharmaceuticals Inc. 54.7%

Value $35.94M Shares 3,540,777 Est. Cost $28.69 Unrealized -76.6%

— Surrozen, Inc. 20.4%

Value $13.41M Shares 1,499,773 Est. Cost $9.59 Unrealized —

— RAPT Therapeutics Inc 16.2%

Value $10.63M Shares 1,328,613 Est. Cost $19.03 Unrealized —

TNYA Tenaya Therapeutics, Inc. 8.7%

Value $5.744M Shares 9,400,290 Est. Cost $21.49 Unrealized -97.6%

RVMD Revolution Medicines Inc 0.0%

Value $1,692 Shares 46 Est. Cost $34.24 Unrealized +12.2%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ORIC	ORIC Pharmaceuticals Inc.	3,540,777	$35.94M	54.7%	$28.69	-76.6%	COM	68622P109
—	Surrozen, Inc.	1,499,773	$13.41M	20.4%	$9.59	—	COM	86889P109
—	RAPT Therapeutics Inc	1,328,613	$10.63M	16.2%	$19.03	—	COM	75382E109
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$5.744M	8.7%	$21.49	-97.6%	COM	87990A106
RVMD	Revolution Medicines Inc	46	$1,692	0.0%	$34.24	+12.2%	COM	76155X100